Am­gen's Neu­las­ta gains an­oth­er biosim­i­lar com­peti­tor as sales slip

Neu­las­ta, one of Am­gen’s old­est drug fran­chis­es, has an­oth­er biosim­i­lar to con­tend with.

Ger­man phar­ma Fre­se­nius Kabi an­nounced on Tues­day that the FDA has ap­proved …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER